SE8701934L - Okad expression av humant interleukin-2 i deggdjursceller - Google Patents

Okad expression av humant interleukin-2 i deggdjursceller

Info

Publication number
SE8701934L
SE8701934L SE8701934A SE8701934A SE8701934L SE 8701934 L SE8701934 L SE 8701934L SE 8701934 A SE8701934 A SE 8701934A SE 8701934 A SE8701934 A SE 8701934A SE 8701934 L SE8701934 L SE 8701934L
Authority
SE
Sweden
Prior art keywords
expression
unclaimed
human interleukin
cancer cells
interleukin
Prior art date
Application number
SE8701934A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Other versions
SE8701934D0 (sv
Inventor
B R Cullen
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SE8701934D0 publication Critical patent/SE8701934D0/xx
Publication of SE8701934L publication Critical patent/SE8701934L/

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SE8701934A 1986-05-12 1987-05-11 Okad expression av humant interleukin-2 i deggdjursceller SE8701934L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/862,082 US4992367A (en) 1986-05-12 1986-05-12 Enhanced expression of human interleukin-2 in mammalian cells

Publications (2)

Publication Number Publication Date
SE8701934D0 SE8701934D0 (sv) 1987-05-11
SE8701934L true SE8701934L (sv) 1987-11-13

Family

ID=25337602

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8701934A SE8701934L (sv) 1986-05-12 1987-05-11 Okad expression av humant interleukin-2 i deggdjursceller

Country Status (25)

Country Link
US (1) US4992367A (el)
JP (1) JPS62278994A (el)
AR (1) AR241794A1 (el)
AT (1) AT389892B (el)
AU (1) AU603576B2 (el)
BE (1) BE1000717A5 (el)
CH (1) CH675731A5 (el)
DE (1) DE3715808A1 (el)
DK (1) DK234087A (el)
ES (2) ES2006476A6 (el)
FI (1) FI872096A (el)
FR (1) FR2598433B1 (el)
GB (1) GB2190382B (el)
GR (1) GR870727B (el)
HU (1) HU205384B (el)
IL (1) IL82475A0 (el)
IT (1) IT1215478B (el)
LU (1) LU86874A1 (el)
MC (1) MC1821A1 (el)
NL (1) NL8701132A (el)
NO (1) NO871939L (el)
NZ (1) NZ220246A (el)
PT (1) PT84849B (el)
SE (1) SE8701934L (el)
ZA (1) ZA872768B (el)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3014099B2 (ja) * 1987-08-26 2000-02-28 バイオジェン インコーポレイテッド 生物的材料、生物的材料の生産およびこの種の材料の治療への使用方法
FR2619719B1 (fr) * 1987-09-01 1991-05-10 Sanofi Sa Procede d'obtention d'interleukine-2 a partir de cellules eucaryotes, vecteurs necessaires a sa mise en oeuvre et lignees cellulaires hautement productrices
FR2636231A1 (fr) * 1988-09-09 1990-03-16 Sanofi Sa Cellules eucaryotes recombinees productrices d'interleukine-1 (beta) mature n-glycosylee, procede et vecteurs necessaires pour leur obtention et procede d'obtention d'interleukine-1 (beta) mature n-glycosylee
WO1990010069A1 (en) * 1989-02-28 1990-09-07 Institut Organicheskogo Sinteza Akademii Nauk Latviiskoi Ssr RECOMBINANT PLASMID DNA pAA 1213-23 AND pAC 262-33 CODING FOR SYNTHESIS OF HUMAN INTERLEUKIN-2, METHOD OF THEIR CONSTRUCTION AND STRAIN OF BACTERIA ESCHERICHIA COLI RRI/pAC 262-33 AS PRODUCER OF HUMAN INTERLEUKIN-2
IL95330A0 (en) * 1989-08-11 1991-06-30 Lilly Co Eli Expression of a functional insect specific toxin gene in mammalian cells
GB9106185D0 (en) * 1991-03-22 1991-05-08 Wellcome Found Biological control agents
US5856178A (en) * 1993-08-30 1999-01-05 Utah State University DNA cassettes for expression of lytic peptides in mammalian cells and transgenic organisms containing same
US5548075A (en) * 1993-08-30 1996-08-20 Utah State University DNA cassette and transgenic organisms carrying lytic peptide-encoding genes
US5641665A (en) * 1994-11-28 1997-06-24 Vical Incorporated Plasmids suitable for IL-2 expression
US5686246A (en) * 1995-08-03 1997-11-11 Kornman; Kenneth S. Detecting genetic predisposition to periodontal disease
CN1200037A (zh) 1995-10-17 1998-11-25 韦恩州立大学 鸡白细胞介素－15及其用途
US6001613A (en) * 1996-05-24 1999-12-14 Board Of Regents Of University Of Nebraska Plasmid bearing a cDNA copy of the genome of bovine viral diarrhea virus, chimeric derivatives thereof, and method of producing an infectious bovine viral diarrhea virus using said plasmid
AUPP655698A0 (en) * 1998-10-16 1998-11-05 Commonwealth Scientific And Industrial Research Organisation Delivery system for porcine somatotropin
US20070025958A1 (en) 2000-10-27 2007-02-01 Hadden John W Vaccine immunotherapy
KR20020043448A (ko) * 2000-12-04 2002-06-10 리송알렉스인근 인터루킨-2 재조합 단백질 및 그의 제조방법
US20040071671A1 (en) * 2001-02-20 2004-04-15 Leturcq Didier J. Cell therapy method for the treatment of tumors
JP2006510567A (ja) * 2001-02-20 2006-03-30 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 腫瘍の治療のための細胞治療方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2814039C3 (de) * 1978-03-31 1981-02-19 Gesellschaft Fuer Biotechnologische Forschung Mbh (Gbf), 3300 Braunschweig Verfahren zur Herstellung von Hybrid-Bakterien
US4405712A (en) * 1981-07-01 1983-09-20 The United States Of America As Represented By The Department Of Health And Human Services LTR-Vectors
DE3377363D1 (en) * 1982-03-31 1988-08-18 Ajinomoto Kk Gene coding for interleukin-2 polypeptide, recombinant dna carrying said gene, cell lines possessing the recombinant dna,and method for producing interleukin-2 using said cells
AU556353B2 (en) * 1982-12-15 1986-10-30 Ajinomoto Co., Inc. Interleukin-2 polypeptide
AU579089B2 (en) * 1983-02-08 1988-11-17 Biogen, Inc. Human interleukin-2-like polypeptides
IL71275A0 (en) * 1983-03-21 1984-06-29 Sparamedica Ag Human interleukin-2-and its preparation
WO1985000817A1 (en) * 1983-08-10 1985-02-28 Amgen Microbial expression of interleukin ii
GB8327880D0 (en) * 1983-10-18 1983-11-16 Ajinomoto Kk Saccharomyces cerevisiae
EP0162898A4 (en) * 1983-11-14 1987-07-23 Chiron Corp INTERLEUKIN-2 GENERATION USING CLONED GENES FOR INTERLEUKIN-2 AND YEAR ALPHA FACTOR.
FR2559782B1 (fr) * 1984-02-16 1986-07-18 Transgene Sa Vecteur d'expression dans les levures de l'interleukine-2, levures transformees et procede de preparation de l'interleukine-2
EP0163603B1 (en) * 1984-05-08 1989-12-13 Genetics Institute, Inc. A human t-cell growth factor
DE3419995A1 (de) * 1984-05-29 1985-12-05 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von human-interleukin-2 und mittel zur durchfuehrung dieses verfahrens
EP0172619A1 (en) * 1984-06-20 1986-02-26 Takeda Chemical Industries, Ltd. Novel transformant and use thereof
CA1275954C (en) * 1984-08-31 1990-11-06 Hing Cheug Wong 3'-expression enhancing fragments and method
FR2583770B1 (fr) * 1985-06-21 1988-08-19 Transgene Sa Expression de l'il-2 humaine dans les cellules de mammiferes par un poxvirus recombine
FR2619719B1 (fr) * 1987-09-01 1991-05-10 Sanofi Sa Procede d'obtention d'interleukine-2 a partir de cellules eucaryotes, vecteurs necessaires a sa mise en oeuvre et lignees cellulaires hautement productrices

Also Published As

Publication number Publication date
GB2190382A (en) 1987-11-18
HU205384B (en) 1992-04-28
IL82475A0 (en) 1987-11-30
HUT45558A (en) 1988-07-28
ZA872768B (en) 1988-04-27
ES2006476A6 (es) 1989-05-01
IT8720479A0 (it) 1987-05-12
DK234087A (da) 1987-11-13
GB2190382B (en) 1990-08-15
BE1000717A5 (fr) 1989-03-21
DK234087D0 (da) 1987-05-08
IT1215478B (it) 1990-02-14
JPS62278994A (ja) 1987-12-03
ATA263787A (de) 1989-07-15
AU7270387A (en) 1987-11-19
CH675731A5 (el) 1990-10-31
AR241794A1 (es) 1992-12-30
SE8701934D0 (sv) 1987-05-11
NO871939D0 (no) 1987-05-11
LU86874A1 (fr) 1988-06-13
NO871939L (no) 1987-11-13
GR870727B (en) 1987-09-21
US4992367A (en) 1991-02-12
PT84849B (pt) 1990-02-08
MC1821A1 (fr) 1988-03-18
FR2598433A1 (fr) 1987-11-13
GB8711072D0 (en) 1987-06-17
NL8701132A (nl) 1987-12-01
AT389892B (de) 1990-02-12
DE3715808A1 (de) 1987-12-10
NZ220246A (en) 1990-07-26
FR2598433B1 (fr) 1990-09-21
AU603576B2 (en) 1990-11-22
ES2012940A6 (es) 1990-04-16
PT84849A (pt) 1987-06-01
FI872096A (fi) 1987-11-13
FI872096A0 (fi) 1987-05-12

Similar Documents

Publication Publication Date Title
SE8701934L (sv) Okad expression av humant interleukin-2 i deggdjursceller
NO890587D0 (no) Nye proteiner med faktor viii aktivitet: fremgangsmaate for fremstilling derav ved anvendelse av genetisk omkonstruerte celler og farmasoeytiske sammensetninger som inneholder disse.
MY102029A (en) Human factor viii, compositions containing it, methods and materials for use in its production
IL112585A (en) N-terminally chemically modified G-CSF and analogs process for their preparation and pharmaceutical compositions containing them
ES8505405A1 (es) Un procedimiento para producir un activador de plasminogeno purificado.
ES8604582A1 (es) Un metodo para preparar derivados de piperazina
ES554186A0 (es) Procedimiento de preparar derivados benzonaftalenicos de utilidad terapeutica y cosmetica
NO169347C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive polypeptider
IT1207992B (it) Derivati glicosilati dell'insulina.
ES2068913T3 (es) Peptolidos que contienen acido pipecolico, su preparacion y composiciones farmaceuticas que los contienen.
ES8605296A1 (es) Procedimiento de producir factor viii-r humano
KR880009127A (ko) 용성 성숙 hIL-β 및 변경된 생물학적 활성을 갖는 유도체를 이 콜라이에서 고도로 발현시키는 플라즈미드 및 그 방법
ES2000582A6 (es) Una composicion transparente de silicona, util para preparar composiciones transparentes para el cuidado personal
EP0516845A4 (en) NEW MEGAKARYOCYTIC COLONY-STIMULATING FACTOR AND METHOD FOR THE PRODUCTION THEREOF.
ES8606898A1 (es) Un procedimiento para producir un factor regulador de cancerendogeno humano
EP0327360A3 (en) Novel polypeptides and dna encoding said polypeptides
FI895183A0 (fi) Foerfarande foer selektiv spjaelkning av fusionsproteiner.
JPS57212194A (en) Hepatic basic protein and its preparation
JPS57136526A (en) Preparation of blood coagulation factor 8
JPS6439999A (en) Stabilization of myc protein, variant myc gene, recombinant plasmid containing said gene and production of variant myc protein using transformant by said recombinant plasmid
ATE141104T1 (de) Gentechnische herstellung von protein pp 15.
DE3377415D1 (en) Novel phenylpiperazine derivatives, process for preparing them and therapeutic compositions containing them
MX9605986A (es) Analogos sinteticos de peptidos de la proteina de la superficie pulmonar sp-c.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8701934-5

Effective date: 19930319